Medical imaging is a major healthcare industry worldwide, serviced by ultrasound, computed tomography (CT), nuclear medicine, X-ray, MRI and PET services.

The market for the outcomes of the CRC is broadly defined as functional and structural medical imaging, and more specifically:

·	New and improved radiopharmaceuticals, together with chemical processes for their production.
·	New detectors capable of significantly improved sensitivity and resolution, with application to PET, CT and radiography.

These outcomes are relevant to:

·	Equipment vendors through improved imaging equipment and related products.
·	Healthcare service providers through benefits provided by better equipment.

Healthcare benefits are provided by specific diagnostic and therapy management techniques based on the radiotracers and detectors being developed. Significant healthcare savings can result from appropriate individualised treatments guided by biomedical imaging.

The technologies being developed by CRC BID lend themselves to breakthrough applications in a range of fields, including non-medical. Therefore, CRC BID runs a program to foster engagement with industry by providing customised imaging solutions.

 

> Go to Commercial Activities